The American Culture of Clinical Oncology–University of American Pathologists (ASCO–CAP) suggestions have ongoing to evolve to improve the accuracy and clinical utility of HER2 screening by giving precise algorithms15,16. In parallel with present procedures, novel ways to quantify HER2 stages or standardize procedures are now being investigated, which includes quantitative https://www.directivepublications.org/journal-of-clinical-breast-cancer/